New Delhi: Serum Institute of India (SII) is expected to begin clinical trials of Novavax’s COVID-19 vaccine ‘Covovax’ for children…
Novavax’s COVID-19 vaccine Covovax, to be also made in this country by Serum Institute of India (SII), has been found…
New Delhi: Serum Institute of India (SII) got the approval to conduct Phase 2 and 3 clinical trials for Novavax’s…
Pune: India's premier vaccine manufacturer, Serum Institute of India (SII), has sought permission from Drugs Controller General of India (DCGI)…
Even if a coronavirus vaccine is developed successfully by early next year, there won’t be enough to administer all global…
India’s Serum Institute and Novavax Inc whose COVID-19 vaccine candidate showed promising results in the initial clinical trials have signed…